| Financial Year |
March 31 2023 |
| Monetary Funds |
4,718,017,090.02 |
| Held-for-trading Financial Assets |
20,157,054.25 |
| Notes Receivable |
-- |
| Accounts Receivable |
419,051,462.77 |
| Advances to Suppliers |
94,159,971.74 |
| Other Receivables |
103,057,481.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,590,836.94 |
| Dividend Receivable |
-- |
| Inventories |
452,183,714.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
113,296,411.39 |
| Other Current Assets |
2,446,444,969.90 |
| Total Current Assets |
8,954,121,359.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
253,498,076.07 |
| Long-term Equity Investment |
2,497,398,515.82 |
| Investment Properties |
185,156,959.38 |
| Fixed Assetes |
1,777,957,033.87 |
| Under-construction Projects |
29,330,416.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,451,005,000.75 |
| R&D expenses |
-- |
| Goodwill |
346,781,051.59 |
| Long-Term Deferred and Prepaid Expenses |
194,440,812.94 |
| Deferred Income Tax Assets |
138,599,091.14 |
| Other Non-Current Assets |
563,547,377.37 |
| Sub-Total of Non-Current Assets |
49,451,818,890.12 |
| Total Assets |
58,405,940,250.05 |
| Short-Term Loans |
3,148,756,601.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
179,420,000.00 |
| Accounts Payable |
277,229,749.32 |
| Accounts Received In Advance |
17,613,462.87 |
| Employee Compensation Payable |
149,579,488.28 |
| Taxes Payable |
106,760,325.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
574,835,532.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,289,323,979.78 |
| Other Current Liabilities |
3,689,980,731.91 |
| Sub-Total of Current Liabilities |
20,883,521,488.31 |
| Long-term Loans |
23,231,030,747.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,596,377.40 |
| Special Payable |
-- |
| Estimatied Liabilities |
20,937,900.00 |
| Deferred Income Tax Liabilities |
143,718,622.33 |
| Other Non-Current Liabilities |
14,379,682.55 |
| Sub-Total of Non-Current Liabilities |
23,565,831,805.49 |
| Total Liabilities |
44,449,353,293.80 |
| Paid-In Capital(Or Share Stock) |
1,517,828,334.00 |
| Capital Surplus |
47,725,344.54 |
| Surplus Reserve |
1,245,000,373.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,637,127,780.77 |
| Minority Stockholder's Interest |
1,823,784,371.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,132,802,585.18 |
| Owner's Equity（Stockholder's Equity） |
13,956,586,956.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
58,405,940,250.05 |
